# FDA Inspection 1191049 - Liptis Pharmaceuticals USA Inc. - November 02, 2022

Source: https://www.keypedia.com/records/fda_inspections/liptis-pharmaceuticals-usa-inc/9b6c2143-eb63-48cd-a016-79198fc84cc2
Source feed: FDA_Inspections

> FDA Inspection 1191049 for Liptis Pharmaceuticals USA Inc. on November 02, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191049
- Company Name: Liptis Pharmaceuticals USA Inc.
- Inspection Date: 2022-11-02
- Classification: No Action Indicated (NAI)
- Project Area: Foodborne Biological Hazards
- Product Type: Food/Cosmetics
- Office Name: Center for Food Safety and Applied Nutrition

## Related Documents

- [FDA Inspection 1191049 - 2022-11-02](https://www.keypedia.com/records/fda_inspections/liptis-pharmaceuticals-usa-inc/5775f525-1154-4dc8-9273-cdd77d09a927)

Company: https://www.keypedia.com/companies/liptis-pharmaceuticals-usa-inc/06ac9be2-8775-4664-b04b-dc6658fbbe10

Office: https://www.keypedia.com/offices/center-for-food-safety-and-applied-nutrition/e04dc4e5-ee4f-4b0d-be8c-1139531ddab2